AR014000A1 - Metodo para utilizar inhibidores de ciclooxigenasa-2 en el mantenimiento del ductus ateriosus fetal durante el tratamiento y la prevencion del trabajode parto prematuro - Google Patents
Metodo para utilizar inhibidores de ciclooxigenasa-2 en el mantenimiento del ductus ateriosus fetal durante el tratamiento y la prevencion del trabajode parto prematuroInfo
- Publication number
- AR014000A1 AR014000A1 ARP980105483A ARP980105483A AR014000A1 AR 014000 A1 AR014000 A1 AR 014000A1 AR P980105483 A ARP980105483 A AR P980105483A AR P980105483 A ARP980105483 A AR P980105483A AR 014000 A1 AR014000 A1 AR 014000A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- work
- arylamine
- cyclooxygenase
- inhibitors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/06—Anti-spasmodics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6388997P | 1997-10-31 | 1997-10-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR014000A1 true AR014000A1 (es) | 2001-01-31 |
Family
ID=22052179
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980105483A AR014000A1 (es) | 1997-10-31 | 1998-10-30 | Metodo para utilizar inhibidores de ciclooxigenasa-2 en el mantenimiento del ductus ateriosus fetal durante el tratamiento y la prevencion del trabajode parto prematuro |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1027048A2 (pt) |
| JP (1) | JP2001521889A (pt) |
| AR (1) | AR014000A1 (pt) |
| AU (1) | AU758566B2 (pt) |
| BR (1) | BR9813164A (pt) |
| CA (1) | CA2308639A1 (pt) |
| TW (2) | TW577739B (pt) |
| WO (1) | WO1999022720A2 (pt) |
| ZA (1) | ZA989876B (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1353664A2 (en) * | 2000-06-08 | 2003-10-22 | The Board Of Regents, The University Of Texas System | Heterocycle derivatives and methods of use for treating anthrax infection |
| PL1534305T3 (pl) | 2003-05-07 | 2007-03-30 | Osteologix As | Leczenie zaburzeń chrząstek i kości solami strontu rozpuszczalnymi w wodzie |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994026731A1 (en) * | 1993-05-13 | 1994-11-24 | Merck Frosst Canada Inc. | 2-substituted-3,4-diarylthiophene derivatives as inhibitors of cyclooxygenase |
| US5474995A (en) * | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
| US5466823A (en) * | 1993-11-30 | 1995-11-14 | G.D. Searle & Co. | Substituted pyrazolyl benzenesulfonamides |
| EP0889724A1 (en) * | 1996-02-27 | 1999-01-13 | Rpms Technology Limited | Cox-2 selective inhibitors for managing labour and uterine contractions |
| US5677318A (en) * | 1996-07-11 | 1997-10-14 | Merck Frosst Canada, Inc. | Diphenyl-1,2-3-thiadiazoles as anti-inflammatory agents |
-
1998
- 1998-10-27 BR BR9813164-8A patent/BR9813164A/pt not_active Application Discontinuation
- 1998-10-27 WO PCT/US1998/022246 patent/WO1999022720A2/en active IP Right Grant
- 1998-10-27 CA CA002308639A patent/CA2308639A1/en not_active Abandoned
- 1998-10-27 JP JP2000518654A patent/JP2001521889A/ja not_active Withdrawn
- 1998-10-27 AU AU11926/99A patent/AU758566B2/en not_active Ceased
- 1998-10-27 EP EP98955026A patent/EP1027048A2/en not_active Ceased
- 1998-10-29 ZA ZA9809876A patent/ZA989876B/xx unknown
- 1998-10-30 AR ARP980105483A patent/AR014000A1/es not_active Application Discontinuation
- 1998-10-30 TW TW087118094A patent/TW577739B/zh not_active IP Right Cessation
- 1998-10-30 TW TW092134686A patent/TW200404535A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2001521889A (ja) | 2001-11-13 |
| AU1192699A (en) | 1999-05-24 |
| EP1027048A2 (en) | 2000-08-16 |
| TW200404535A (en) | 2004-04-01 |
| TW577739B (en) | 2004-03-01 |
| CA2308639A1 (en) | 1999-05-14 |
| WO1999022720A2 (en) | 1999-05-14 |
| BR9813164A (pt) | 2000-08-22 |
| AU758566B2 (en) | 2003-03-27 |
| WO1999022720A3 (en) | 1999-08-26 |
| ZA989876B (en) | 1999-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CU23116A3 (es) | Derivados de bencensulfonamida sustituida, como inhibidores de cox-2 | |
| NZ509755A (en) | Method of using benzenesulphoamides that are cyclooxygenase-2-inhibitors in the treatment and prevention of neoplasia | |
| PT772597E (pt) | Pirazoles 3,4-substituidos para o tratamento de inflamacao | |
| MX2021015605A (es) | Compuestos 2,3-dihidroquinazolin como inhibidores nav1.8. | |
| HU9701605D0 (en) | New substituted biphenyl or phenylpiridine compounds, a process for their preparation and pharmaceutical composition containing them | |
| BRPI0413848A (pt) | composto, processo para preparar o composto, composição terapêutica para prevenir inflamação e apoptose, método para prevenir inflamação e apoptose, e, uso de composto inibidor de caspase, ou de seu sal, ou de seu estereoisÈmero | |
| ZA944501B (en) | Phenyl heterocycles as cox-2 inhibitors | |
| PL356252A1 (en) | Synergistic combination of pde inhibitors and beta 2 adrenoceptor agonist | |
| MY126917A (en) | Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors | |
| CY1107069T1 (el) | Χρηση των αναστολεων της cox-2 σαν ανοσοδιεγερτες στη θεραπεια του hiv ή του aids | |
| ES2120728T3 (es) | Inhibidores de la agregacion de plaquetas. | |
| AR014000A1 (es) | Metodo para utilizar inhibidores de ciclooxigenasa-2 en el mantenimiento del ductus ateriosus fetal durante el tratamiento y la prevencion del trabajode parto prematuro | |
| PT880504E (pt) | Imidazoles substituidos por heterociclo para o tratamento de inflamacao | |
| DK0659193T3 (da) | Blodpladeaggregationsinhibitorer | |
| BRPI0417007A (pt) | agentes antivirais de diazaindol-dicarbonil-piperazinila | |
| CR20210143A (es) | Utilización de un inhibidor de catepsina s contra la formación de anticuerpos anti-fármaco | |
| AR038199A1 (es) | Terapia combinada para el tratamiento de infecciones bacterianas | |
| HUP9901505A2 (hu) | Dehidroepiandroszteron és aromatázgátlók kombinációja és e kombináció felhasználása férfiak relatív és abszolút androgénhiányának kezelésére szolgáló gyógyszerkészítmények előállítására | |
| BRPI0407039A (pt) | Uso de uma combinação de um inibidor de aromatase, uma progestina e um estrogênio, composição farmacêutica, e, método do tratamento de endometriose | |
| FR3077201B1 (fr) | Derives aminoacides contenant un groupement disulfanyle sous forme d'un inhibiteur de nep et d'apn pour la prevention et le traitement des douleurs relatives au nerf trijumeau | |
| AR020306A1 (es) | Composicion terapeutica y su uso como inhibidora de la ciclooxigenasa-2 en la prevencion de alteraciones cardiovasculares. | |
| CL2008003412A1 (es) | Uso de compuestos no beta-oxidables de formula r"-coo-(ch2)2n+1-x-r para preparar una composicion nutricional y/o farmaceutica par inhibir la maduracion sexual de peces. | |
| AR035768A1 (es) | Compuesto derivado de bencimidazol y su uso en la fabricacion de un medicamento | |
| AR012310A1 (es) | Composicion de 4-[pirazol-1-il]-benceno-sulfonamida inhibidora de la ciclooxigenasa-2 util en el tratamiento y la prevencion de la demencia y su usopara preparar un medicamento para tratar ese mal. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal | ||
| FB | Suspension of granting procedure |